Insights & Resources | Pfizer CentreOne

News & Updates

Pfizer CentreOne Newsletter January 2021 Edition

At Pfizer CentreOne, we are proud of the trust you placed in our organization, whether it’s for securing your API or intermediates supply, or developing and commercializing your products. Together with you, we draw inspiration from our purpose to help patients in need, and that has never been more important than it is now.

News & Updates

The Power of People: What I Learned About My Team

The foundation of any great team is the strong connection among its members. I started my role as the GM of Pfizer CentreOne during the pandemic and was concerned about establishing relationships virtually. Two months later, I have yet to meet any of my team members face-to-face. However, the connections I’ve already made across the team are strong and they have made quite the impression.

Expert Content

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

Brochure

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Expert Content

Pfizer CentreOne's Partnership Promise

Strong commercial partnerships are based on trust and lasting relationships. For this reason, organizational changes can be unsettling. What will the new leader bring? What impact will the change have on my partnership? These are valid questions that should be addressed.

Expert Content

Infographic | Embedded CDMO Misconceptions

Access to the expert capabilities of embedded CDMOs is offering great economies and competitive experience. However, embedded CDMOs are still surrounded by misconceptions. In this infographic, Karen Lauxmann, Contract Manufacturing European Sales Lead, addresses 8 of the most common misconceptions we encounter at Pfizer CentreOne as an embedded CDMO.

News & Updates

Fifth consecutive CMO Leadership Award demonstrates our continued commitment to being a partner of choice

We’re engaging our customers more meaningfully than ever and the results of this intelligent collaboration approach are showing.

News & Updates

Pfizer CentreOne Wins CMO Leadership Award for Fifth Consecutive Year

Pfizer CentreOne, the global contract development and manufacturing organization (CDMO) embedded within Pfizer, has been selected as a winner of six 2021 CMO Leadership Awards presented by Outsourced Pharma and Life Science Leader. Pfizer CentreOne was named a leader by both big and small pharma across all award categories – Capabilities, Compatibility, Expertise, Quality, Reliability, Service.

News & Updates

Pfizer CentreOne enters the ring with vibrant new API & Intermediates campaign

Pfizer CentreOne, the global pharmaceutical contract development and manufacturing organization (CDMO) embedded within Pfizer, has launched a vibrant new campaign for its API & Intermediates supply offering with the theme of ‘In Your Corner’.

Expert Content

Culture of Confidentiality: Our Promise to Customers

When speaking to potential customers, we often encounter the misconception that partnering with an embedded CDMO like Pfizer CentreOne puts your intellectual property (IP) at risk. Yet this is not at all the case.

Expert Content

A Year in Review: 2020 API Supply Chain Trends and 2021 Predictions

It has been extremely gratifying for everyone here in Kalamazoo, Michigan to have been in pharma’s corner in 2020, helping the industry from behind the scenes, manufacturing and delivering supplies of critical treatments. I am extremely proud to be a part of Pfizer CentreOne’s central role helping meet spiking demand and ensuring medicines reached patients through our partnerships and secure supply chain.

Expert Content

Looking ahead: Today’s technical trends shaping 2021 priorities

A range of new treatment and administration routes are being introduced to pharma’s pipeline, bringing new complexities and prompting demand for experienced CDMOs. The pipeline’s trajectory is requiring new clinical manufacturing infrastructures and the need to find and engage contract partners with enough development and commercial experience to get the job done has never been higher—or more important to overall drug development strategy.

Header image of scientist for 2021 CDMO trends blog